KUNMING, China, June 14 /Xinhua-PRNewswire-FirstCall/ -¨C China Shenghuo Pharmaceutical Holdings, Inc. announced the listing of its common stock on the American Stock Exchange on Thursday, June 14, 2007, and the closing of a public offering of its common stock at an offering price of $3.50 per share on Thursday, June 14, 2007....   more

Shanghai. June 20. INTERFAX-CHINA - Inefficient intellectual property rights protection is a factor preventing multinational companies from outsourcing pharmaceutical R & D and production to China, business insiders said at the 2007 CPhI International Forum in Shanghai yesterday....   more

China\'s resolve to clean up corruption in its pharma industry has intensified as the former assistant to the already-condemned-to-death former drug chief has now been charged....   more

To conscientiously strengthen the publicity and be actively supervised by public opinions The center for Drug Evaluation will enlarge the announcement range of reviewers New trends in the evaluating policies for TCM registration: Special evaluation on the innovative drugs and the higher access standards for TCM varieties under protection Recruitment for members of the “Technical Subcommittee of Dental Devices and Instruments for the National Technical Standardization Committee for Dental Materials and Instruments” The Provisions of Drug Advertising Review are revised, and the illegal advertisements will be seriously punished The new version of Drug Advertising Review and Dissemination Standards was published SFDA issued a notice on matters relating to drug re-registration...   more

The General office of the state Council issued the Eleventh Five-year Plan of the National Food and Drug Safety The Technical Guidelines for the Clinical Study of the In Vitro Diagnostic Reagents and the Guidelines for the Inert Sheet Compilation of In Vitro Diagnostic Reagents were Issued The “Study of Techniques of Fast Inspection on Drugs and the Application of its Carries-Drug Inspection Van” Program passed the form examination of the National Awards Office The Administrative Measures for In Vitro Diagnostic Reagents Registration (Interim) have been issued SFDA issued new requirements for GLP certification Provision for Drug Registration (Draft for Comment) Workshop was held The Second International Pharmaceutical R&D Forum was held in Beijing...   more

Alpharma Pharmaceutical Co. has completed its agreement with Zhejiang Hisun Pharmaceutical Co. (Hisun), doubling its capacity to manufacture one of Hisun\'s major APIs, vancomycin, subject to FDA and European regulatory approvals. Vancomycin is for severe gram-positive hospital infections. Alpharma currently manufactures vancomycin at its sites in Copenhagen, Denmark and Budapest, Hungary....   more

10/07/2007 - China has wasted no time in executing the first of its convicted corrupt former drug officials after his desperate appeal for life failed....   more

06/07/2007 - A second former State Food and Drug Administration (SFDA) official was slammed with the death penalty over a corruption scandal that first broke last year....   more

Outsourcing powerhouse WuXi PharmaTech is rumored to be on the verge of announcing its IPO. The Shanghai-based company has been a huge success story right from the outset of its 2001 startup, now boasting 1,550 scientific staff members and over 2,000 employees overall....   more

GlaxoSmithKline (GSK) said yesterday that it will spend US$40 million this year to start a research facility in Shanghai that will grow into one of its largest research centers globally....   more

A senior Chinese food regulator has warned that problems with food safety in the country could cause diseases and threaten social stability....   more

China\\\'s pharmaceutical watchdog will tighten the approval procedures for new medicines with the revised regulation on medicine registration taking effect on Oct. 1....   more

China, facing international criticism over the quality of food and drug exports, said it will take five years to stamp out production of fake medicine and that the trend in safety is not promising....   more

China food and drug watchdog has revoked the production licenses of five drug manufacturers since last July....   more

The chemical industry is the third largest in China, after textiles and machinery, and accounts for 10% of the country’s GDP, as well as for between 35% and 40% of the global demand growth for chemicals. China’s chemical industry is the second largest consumer, after the US, of basic chemical products - fully 45% of the total for Asia. The estimated growth in domestic demand for chemicals in 2005-2006 is now estimated at seven to eight percent...   more

China Sky One Medical, Inc. , a manufacturer, marketer and distributor of pharmaceutical, medicinal and diagnostic products in China, today announced that its facilities and products passed a surprise inspection by China State Food and Drug Administration (SFDA) on June 28, 2007. Government officials and industry professionals working for the SFDA inspected the Company\\\\\\\'s production process, including the quality of raw materials, final packaging, consumer instructions, as well as stock-keeping methods...   more

Sinovac Biotech Ltd. , a leading provider of biopharmaceutical products in China, today announced it has entered into an Exclusive Promotion Service Agreement with GlaxoSmithKline (China) Investment Co., Ltd. (or GSK China). GSK China and Sinovac will market and promote Anflu(R), a seasonal influenza vaccine developed and manufactured by Sinovac....   more

WuXi PharmaTech, the biggest Chinese contract research organisation (CRO), has put an end to weeks of speculation by officially announcing it plans an initial public offering (IPO) on the New York Stock Exchange....   more

In February of this year, following several years of frenzied increase, a one-day 8% decline in the markets in China caused jitters throughout the world. Pundits responded by using the derogatory term bubble to describe China’s stock market. But China recovered from that decline – and from several other smaller, subsequent ones – and now finds itself, once again, at record levels....   more

ChinaBio Today submits: The execution of former head of the Chinese FDA, Zheng Xiaoyu, for bribery was the big story last week in the world of Chinese biotech (see story). To Americans, the story was shocking, both because death sentences are not meted out for white collar crimes in the U.S., and because of the speed with which the sentence was carried out. How long does the average prisoner sit on death row in the U.S.? While Zheng appealed the sentence (though not the verdict), the appeal was heard in six weeks time, and Zheng was summarily executed immediately after the decision was handed down. A written confession from Zheng was published, in which he admitted actions that led the deaths of at least 10 individuals...   more